Meisel C - Search Results

1

Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant--463A of the myeloperoxidase gene.

Cascorbi I, Henning S, Brockmöller J, Gephart J, Meisel C, Müller JM, Loddenkemper R, Roots I. Cascorbi I, et al. Among authors: meisel c. Cancer Res. 2000 Feb 1;60(3):644-9. Cancer Res. 2000. PMID: 10676648

2

Molecular genetics of cancer susceptibility.

Brockmöller J, Cascorbi I, Henning S, Meisel C, Roots I. Brockmöller J, et al. Among authors: meisel c. Pharmacology. 2000 Sep;61(3):212-27. doi: 10.1159/000028403. Pharmacology. 2000. PMID: 10971208 Review.

3

The platelet glycoprotein Ia C807T polymorphism as risk factor for coronary catheter interventions.

Meisel C, Cascorbi I, Herrmann A, Roots I, Laule M, Stangl V, Stangl K. Meisel C, et al. Blood. 2000 Sep 1;96(5):2002-3. Blood. 2000. PMID: 11041633 Free article. No abstract available.

4

Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene.

Mrozikiewicz PM, Cascorbi I, Ziemer S, Laule M, Meisel C, Stangl V, Rutsch W, Wernecke K, Baumann G, Roots I, Stangl K. Mrozikiewicz PM, et al. Among authors: meisel c. J Am Coll Cardiol. 2000 Nov 1;36(5):1520-5. doi: 10.1016/s0735-1097(00)00925-6. J Am Coll Cardiol. 2000. PMID: 11079652 Free article.

5

How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.

Meisel C, Roots I, Cascorbi I, Brinkmann U, Brockmöller J. Meisel C, et al. Clin Chem Lab Med. 2000 Sep;38(9):869-76. doi: 10.1515/CCLM.2000.126. Clin Chem Lab Med. 2000. PMID: 11097342 Review.

6

The G protein subunit beta3 and early complications after coronary catheter interventions.

Meisel C, Laule M, Cascorbi I, Stangl V, Roots I, Stangl K. Meisel C, et al. Atherosclerosis. 2000 Dec;153(2):523-4. doi: 10.1016/s0021-9150(00)00620-1. Atherosclerosis. 2000. PMID: 11187856 No abstract available.

7

The beta3-adrenergic receptor Trp64Arg mutation is not associated with coronary artery disease.

Stangl K, Cascorbi I, Laule M, Stangl V, Meisel C, Wernecke KD, Ziemer S, Baumann G, Roots I, Hauner H. Stangl K, et al. Among authors: meisel c. Metabolism. 2001 Feb;50(2):184-8. doi: 10.1053/meta.2001.20179. Metabolism. 2001. PMID: 11229427

8

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I. Cascorbi I, et al. Among authors: meisel c. Clin Pharmacol Ther. 2001 Mar;69(3):169-74. doi: 10.1067/mcp.2001.114164. Clin Pharmacol Ther. 2001. PMID: 11240981 Clinical Trial.

9

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.

Brockmöller J, Kirchheiner J, Meisel C, Roots I. Brockmöller J, et al. Among authors: meisel c. Pharmacogenomics. 2000 May;1(2):125-51. doi: 10.1517/14622416.1.2.125. Pharmacogenomics. 2000. PMID: 11256586 Review.

10

Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease.

Meisel C, Cascorbi I, Gerloff T, Stangl V, Laule M, Müller JM, Wernecke KD, Baumann G, Roots I, Stangl K. Meisel C, et al. Atherosclerosis. 2001 Feb 15;154(3):651-8. doi: 10.1016/s0021-9150(00)00679-1. Atherosclerosis. 2001. PMID: 11257266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters